Literature DB >> 26014332

Contrast Ultrasound Imaging of the Aorta Does Not Affect Progression of Atherosclerosis or Cardiovascular Biomarkers in ApoE-/- Mice.

Brendon W Smith1, Douglas G Simpson1, Sandhya Sarwate1, Rita J Miller1, John W Erdman1, William D O'Brien2.   

Abstract

OBJECTIVES: Ultrasound contrast agents (UCAs) enhance cardiovascular ultrasound imaging. Adverse biological effects have occurred after administration of UCAs, and more research is needed for a comprehensive understanding of the risks involved. We used the ApoE(-/-) mouse model of atherosclerosis to characterize the effects of ultrasound and UCAs on atherosclerosis and plasma biomarkers.
METHODS: Male ApoE(-/-) mice (8 weeks old; n = 24) were intravenously infused with a UCA (2 × 10(10) Definity microbubbles per hour; Lantheus Medical Imaging, North Billerica, MA) and exposed to 2.8-MHz center frequency ultrasound (10 Hz pulse repetition frequency, 1.4 microseconds pulse duration, 2 minutes exposure duration, and 2 sites) at 1 of 3 derated peak rarefactional pressure amplitudes (0, 1.9, or 3.8 MPa), and then consumed either a chow or Western diet for 4 weeks (n = 4 per group). Blood plasma samples were collected before ultrasound exposure and at 2 and 4 weeks after exposure and assayed for total cholesterol and von Willebrand Factor (vWF). A pathologist measured atheroma thickness in formalin-fixed, hematoxylin-eosin-stained transverse aorta sections and scored them for severity of atherosclerosis.
RESULTS: Plasma total cholesterol initially averaged 286 mg/dL in the Western diet group and increased to 861 mg/dL after 4 weeks on the diet (P < .0001). Total cholesterol did not increase significantly in the chow diet group. Plasma vWF increased after 2 weeks on the Western diet (P < .0001). Atheroma thickness was greater in animals consuming the Western diet than in chow-fed animals (P < .05). Ultrasound had no significant effect on plasma total cholesterol, plasma vWF, or atheroma thickness.
CONCLUSIONS: Contrast ultrasound did not increase the severity of atherosclerosis or alter cardiovascular biomarkers in the ApoE(-/-) mouse model.
© 2015 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  atherosclerosis; biomarkers; cardiovascular disease; contrast agents; endothelium; microbubbles; ultrasound

Mesh:

Substances:

Year:  2015        PMID: 26014332      PMCID: PMC4471945          DOI: 10.7863/ultra.34.6.1115

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  40 in total

1.  Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study.

Authors:  Sahar S Abdelmoneim; Mathieu Bernier; Christopher G Scott; Abhijeet Dhoble; Sue Ann C Ness; Mary E Hagen; Stuart Moir; Robert B McCully; Patricia A Pellikka; Sharon L Mulvagh
Journal:  Circ Cardiovasc Imaging       Date:  2010-03-16       Impact factor: 7.792

2.  Thinking outside the "box"-the ultrasound contrast controversy.

Authors:  Michael L Main; Jonathan H Goldman; Paul A Grayburn
Journal:  J Am Coll Cardiol       Date:  2007-12-03       Impact factor: 24.094

3.  New quantification methods for carotid intra-plaque neovascularization using contrast-enhanced ultrasound.

Authors:  Zeynettin Akkus; Assaf Hoogi; Guillaume Renaud; Stijn C H van den Oord; Gerrit L Ten Kate; Arend F L Schinkel; Dan Adam; Nico de Jong; Antonius F W van der Steen; Johan G Bosch
Journal:  Ultrasound Med Biol       Date:  2013-10-22       Impact factor: 2.998

4.  The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses.

Authors:  Kevin Wei; Sharon L Mulvagh; Lisa Carson; Ravin Davidoff; Ruvin Gabriel; Richard A Grimm; Stephanie Wilson; Lorrie Fane; Charles A Herzog; William A Zoghbi; Rhonda Taylor; Michael Farrar; Farooq A Chaudhry; Thomas R Porter; Waleed Irani; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2008-10-10       Impact factor: 5.251

5.  Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients.

Authors:  J P Reilly; P A Tunick; R J Timmermans; B Stein; B P Rosenzweig; I Kronzon
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

6.  Ultrasonic microbubble destruction stimulates therapeutic arteriogenesis via the CD18-dependent recruitment of bone marrow-derived cells.

Authors:  John C Chappell; Ji Song; Alexander L Klibanov; Richard J Price
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-10       Impact factor: 8.311

7.  Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience.

Authors:  Melda S Dolan; Simil S Gala; Saritha Dodla; Sahar S Abdelmoneim; Feng Xie; David Cloutier; Michelle Bierig; Sharon L Mulvagh; Thomas R Porter; Arthur J Labovitz
Journal:  J Am Coll Cardiol       Date:  2009-01-06       Impact factor: 24.094

8.  Effects of ultrasound and ultrasound contrast agent on vascular tissue.

Authors:  Steven C Wood; Sible Antony; Ronald P Brown; Jin Chen; Edward A Gordon; Victoria M Hitchins; Qin Zhang; Yunbo Liu; Subha Maruvada; Gerald R Harris
Journal:  Cardiovasc Ultrasound       Date:  2012-07-17       Impact factor: 2.062

9.  Ultrasound-mediated stimulation of microbubbles after acute myocardial infarction and reperfusion ameliorates left-ventricular remodelling in mice via improvement of borderzone vascularization.

Authors:  Jonas Dörner; Rafael Struck; Sebastian Zimmer; Christine Peigney; Georg Daniel Duerr; Oliver Dewald; Se-Chan Kim; Daniela Malan; Thierry Bettinger; Georg Nickenig; Alexander Ghanem
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Histological observation of islet hemorrhage induced by diagnostic ultrasound with contrast agent in rat pancreas.

Authors:  Douglas L Miller; Chunyan Dou; Dorothy Sorenson; Ming Liu
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

View more
  1 in total

1.  Preclinical techniques to investigate exercise training in vascular pathophysiology.

Authors:  Gurneet S Sangha; Craig J Goergen; Steven J Prior; Sushant M Ranadive; Alisa M Clyne
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-01       Impact factor: 5.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.